Discover insights into current market trends, future
opportunities, and emerging technologies such as non-invasive
prenatal testing and advanced genomic analysis.
BOSTON, May 20, 2024
/PRNewswire/ -- According to the latest BCC Research study,
the demand for the Global Prenatal Testing Market is
expected to grow from $10.9 billion
in 2023 and is projected to reach $19.8
billion by the end of 2028, at a compound annual growth rate
(CAGR) of 12.6% during the forecast period of 2023 to 2028.
This report provides a comprehensive overview of the prenatal
testing market covering various technologies and methods for
assessing fetal health during pregnancy. It specializes in genetic
testing, including invasive procedures such as amniocentesis and
non-invasive methods such as NIPT. The global reach of this market
varies from region to region and is primarily focused on genetic
disease screening. Integrated testing strategies have improved
diagnostic accuracy, driven by factors such as increasing maternal
age and technological advances. The report highlights current and
future potential, industry status, trends, and strategies such as
mergers and collaborations, providing valuable insights for
stakeholders and companies aiming to expand their geographic
presence in this space.
The introduction of cell-free fetal DNA testing has
revolutionized prenatal genetic testing by allowing the analysis of
fetal DNA from maternal blood. These tests provide an accuracy
comparable to invasive methods such as amniocentesis, but without
the risk of harm to the fetus, a major advance in prenatal care.
Furthermore, clinical whole-genome sequencing (WGS) has achieved a
diagnostic yield of up to 26% for prenatally diagnosed congenital
anomalies, highlighting its importance in the diagnosis of fetal
anomalies. Future studies using whole-genome sequencing as a
primary diagnostic test are expected to exceed this yield,
providing important clinical insights into prognosis and risk of
recurrence while expanding the reproductive options of intended
parents.
Click here for details to learn more about the
Global Prenatal Testing Market Report.
Key Drivers of the Global Prenatal Testing Market
Increasing Cases of Down Syndrome: As women age, the risk
of their unborn children developing chromosomal defects, such as
Down syndrome, increases significantly. For example, a woman's
chance of developing it at the age of 25 is less than 1 in 1250,
but by the age of 40, this chance increases to about 1 in 100. This
awareness creates a greater demand for prenatal testing to detect
and manage such problems early in pregnancy.
Rising Maternal Age: More women are postponing pregnancy,
increasing the chance that their babies will develop genetic
disorders. Prenatal screening can help parents prepare for
potential health problems and ensure timely medical intervention if
necessary.
Advancements in Technology: Innovations such as
non-invasive tests that analyze fetal DNA in the mother's blood
have greatly improved the accuracy of prenatal testing. These
advances have expanded testing capabilities, fueling market
growth.
Request a Sample Copy of the Global Prenatal
Testing Market Report.
Report Synopsis
Report
Metrics
|
Details
|
Base year
considered
|
2022
|
Forecast Period
considered
|
2023-2028
|
Base year market
size
|
$9.8 billion
|
Market Size
Forecast
|
$19.8
billion
|
Growth Rate
|
CAGR of 12.6% for the
forecast period of 2023-2028
|
Segment
Covered
|
Type, Technology,
Application, End User, and Region
|
Regions
covered
|
North America, Europe,
Asia-Pacific, and Rest of the World (RoW)
|
Countries
covered
|
U.S., Canada, Germany,
the U.K., France, Italy, Spain, China, India, Japan, the Middle
East and South America
|
Key Market
Drivers
|
- Increasing cases of
Down syndrome.
- Rising maternal
age.
- Advancements in
technology.
|
Segmentation Analysis:
Market Segments by Type Analysis:
- Consumables: Materials used in prenatal testing
procedures, like reagents and kits.
- Instruments: Equipment for sample collection and
analysis.
Market Segments by Technology Analysis:
- Noninvasive Techniques: Methods like NIPT that analyze
fetal DNA without invading the mother's body.
- Invasive Techniques: Procedures such as amniocentesis
that involve penetrating the mother's skin for sample
collection.
Market Segments by Application Analysis:
- Neural Tube Defects: Testing for conditions like spina
bifida.
- Down Syndrome: Screening for chromosomal abnormalities
associated with Down syndrome.
- Rare Genetic Disorders: Identifying other genetic
conditions.
Market Segments by End-User Analysis:
- Hospitals: Facilities offering prenatal testing
services.
- Diagnostic Laboratories: Specialized labs
conducting prenatal testing and analysis.
This Global Prenatal Testing Market Report contains
comprehensive information and analysis covering the following key
questions:
- What is the projected market size and growth rate of the
market?
The global prenatal testing market is projected to grow from
$9.8 billion in 2022 to $19.8 billion in 2028, at a compound annual
growth rate (CAGR) of 12.6% during the forecast period.
- What are the key factors driving the growth of the market?
• Increase in Down syndrome.
• Increase in maternal age.
• Advancements in technology.
• Increase in genetic disorders.
- What segments are covered in the market?
This report segments the market based on type, technology,
application, end-user, and region. The market is segmented into
consumables and instruments based on the type. The market is
segmented based on technology into noninvasive and invasive
techniques. Noninvasive techniques are further segmented as
non-invasive prenatal testing (NIPT), maternal serum screening, and
ultrasound-based testing. Invasive techniques are further segmented
as amniocentesis, chorionic villus sampling (CVS), and others. The
market is segmented into neural tube defects, down syndrome, rare
genetic disorders, and others based on application. Based on
end-users, the market is segmented as diagnostic laboratories and
hospitals. Based on region, the market is segmented as North America, Europe, Asia-Pacific, and Rest of the World.
- By Type, which segment will dominate the market by the end of
2028?
Consumables will dominate the market by the end of 2028.
- Which region has the highest market share in the market?
North America holds the highest
share of the market.
Some of the Key Market Players Are:
- 10X GENOMICS
- AGILENT TECHNOLOGIES INC.
- BGI
- EUROFINS SCIENTIFIC
- F. HOFFMANN-LA ROCHE LTD.
- ILLUMINA INC.
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- MEDICOVER GENETICS
- NATERA INC. QIAGEN
- QUEST DIAGNOSTICS INC.
- REVVITY INC.
- THERMO FISHER SCIENTIFIC INC.
- YOURGENE HEALTH
Directly Purchase a copy of the
report with BCC Research.
For further information or to make a purchase, please get in
touch with info@bccresearch.com.
About BCC Research
BCC Research provides objective, unbiased measurement and
assessment of market opportunities with detailed market research
reports. Our experienced industry analysts' goal is to help you
make informed business decisions, free of noise and hype.
Contact Us
Corporate HQ: 50 Milk St. Ste 16,
Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit
our media page for access to our market research library.
Data and analysis extracted from this press release must be
accompanied by a statement identifying BCC Research LLC as the
source and publisher.
Logo:
https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/global-prenatal-testing-market-projected-to-reach-19-8-billion-by-2028--302150016.html
SOURCE BCC Research LLC